Twitter Linkedin

New Equilibrium Bio

Background New Equilibrium Bio
New Equilibrium Bio Virginia Burger, Co-Founder & CEO of New Equilibrium Bio
newequilibriumbio.com

New Equilibrium Biosciences leverages their computational–experimental platform to discover lead drug candidates that regulate intrinsically disordered proteins implicated in cancers and neurodegenerative disorders.

Categories

Tags

Co-investors

RA Capital

University Spinout

MIT
Back to portfolio
Galy Announces Lab-Grown Cotton Deal With Japanese Manufacturer Abridge Featured in NY Times VideaHealth Dental AI Platform Available to 90% of Dental Practices in US Guardian Agriculture Secures $20M Series A Zilla Security Introduces New Suite of Identity Security SaaS Solutions PathAI #20 on List of Top 100 Private Deep Tech Companies Range Bio Announces $5.2M Seed Funding Neural Magic Reveals New Performance Results on 4th Gen AMD EPYC Processors
© Pillar VC 2022 — 500 Boylston St, 9th Floor, Boston, MA 02116